| Postprandial and Basal glucose in type 2 diabetes: assessment and respective impacts. | |
| | |
MedLine Citation:
|
PMID: 21668334 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Abstract The independent contribution of postprandial glucose (PPG) excursions to the overall glucose exposure and its role in the development of both micro- and macrovascular complications of diabetes remain subject to continuing debate in type 2 diabetes. Discussion continues on whether postprandial hyperglycemia is the main contributor to the overall hyperglycemia in fairly well-controlled individuals, whereas basal hyperglycemia becomes the preponderant contributor in poorly controlled patients. The concern about the role of PPG as a risk factor for diabetes complications is related to the controversial data obtained in individuals with impaired glucose tolerance. It remains, however, that the total glucose exposure as reflected by hemoglobin A1c (HbA1c) levels is an undoubted major vascular risk factor. Excluding the contribution of PPG is nonsensical. In support of this position is the fact that the absolute impact of PPG on HbA1c, expressed as percentage levels of HbA1c, remains constant at 1% across the HbA1c continuum in non-insulin-treated type 2 diabetes patients. This key feature clearly depicts the absolute contribution of PPG in contrast to its relative contribution and better explains why PPG contributes to the excess of glycation with the basal hyperglycemia. |
| | |
Authors:
|
Louis Monnier; Claude Colette; David Owens |
Related Documents
:
|
10588944 - Streptozotocin-induced diabetes in human apolipoprotein b transgenic mice. effects on l... 1698584 - The immunosuppressant fk-506 prevents progression of diabetes in nonobese diabetic mice. 19861974 - The ppar-gamma agonist, darglitazone, restores acute inflammatory responses to cerebral... 2121514 - Reduced aminergic synthesis in the hypothalamus of the infertile, genetically diabetic ... 15575024 - Evaluating mechanisms of post-transplant diabetes mellitus. 19579934 - Plasma glucose lowering effect of the wild satureja khuzestanica jamzad essential oil i... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Diabetes technology & therapeutics Volume: 13 Suppl 1 ISSN: 1557-8593 ISO Abbreviation: Diabetes Technol. Ther. Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-06-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100889084 Medline TA: Diabetes Technol Ther Country: United States |
Other Details:
|
Languages: eng Pagination: S25-32 Citation Subset: IM |
Affiliation:
|
1 Laboratory of Human Nutrition and Atherosclerosis, Institute of Clinical Research, University of Montpellier I , Montpellier, France . |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pharmacokinetics and pharmacodynamics of Basal insulins.
Next Document: Basal insulin treatment in type 2 diabetes.